Nine Chapters Capital Management’s Anika Therapeutics ANIK Stock Holding History

Nine Chapters Capital Management’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$412K	Buy	+7,100	New	+$371K	0.91%	38
2017 Q2	–	Sell	-25,300	Closed	-$1.1M	–	66
2017 Q1	$1.1M	Buy	+25,300	New	+$1.21M	1.48%	2
2014 Q3	–	Sell	-19,100	Closed	-$885K	–	983
2014 Q2	$885K	Sell	19,100 -2,100	-10%	-$93.4K	0.07%	375
2014 Q1	$871K	Buy	21,200 +14,500	+216%	+$539K	0.1%	297
2013 Q4	$256K	Sell	6,700 -6,400	-49%	-$197K	0.03%	651
2013 Q3	$313K	Buy	+13,100	New	+$294K	0.04%	538

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Nine Chapters Capital Management's ANIK Position: Q3 2017 in Review

Nine Chapters Capital Management opened a new position in Anika Therapeutics (ANIK) in Q3 2017: 7,100 shares worth $412K. The stake represents 0.91% of the portfolio and ranks #38 among its holdings. This is a return to the name: Nine Chapters Capital Management previously reported a position in ANIK as recently as Q1 2017.

Nine Chapters Capital Management first reported a position in ANIK in Q3 2013 and has held it in 6 quarters since. The position peaked at $1.1M in Q1 2017. 166 funds tracked by Wall St. Rank hold ANIK as of Q3 2017.

Nine Chapters Capital Management held 7,100 shares of Anika Therapeutics worth $412K as of Q3 2017.
Anika Therapeutics was a new Nine Chapters Capital Management position in Q3 2017.
Anika Therapeutics made up 0.91% of Nine Chapters Capital Management's portfolio in Q3 2017, its #38 holding.
Nine Chapters Capital Management first reported a position in Anika Therapeutics in Q3 2013 and has held it in 6 quarters since.
Nine Chapters Capital Management's Anika Therapeutics position peaked at $1.1M in Q1 2017.
166 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2017.

Based on Nine Chapters Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.